Searched for
ACNE VULGARIS TREATMENT
Alembic gets USFDA nod for generic drug for skin conditionAlembic Pharmaceuticals has secured USFDA approval for its generic Tretinoin Cream USP (0.025%), a treatment for acne vulgaris. This ANDA i...- Glenmark, Cosmo get MHRA nod for acne treatment medicationGlenmark Pharmaceuticals and Cosmo Pharmaceuticals have received MHRA approval to market Winlevi, a topical acne treatment for patients age...
- Your nose may be warning you about serious health issues: Vital nasal signals you shouldn't missThe nose provides valuable health cues. Persistent congestion, unusual smells, or changes in appearance could signal health issues. Acne vu...
- Why is retinol considered the antidote to ageing?Retinol is a catch-all term often used to describe vitamin A and other retinoids (a group of fat-soluble compounds consisting of retinol an...
- Does Sun Pharma's specialty portfolio hold key to its performance?According to the FY 2022 annual report of Sun Pharma, it is ranked number 1 in terms of prescriptions with an 8.34% market share in India. ...
- Sun Pharma expands tie-up with Cassiopea for acne cream to six countriesAs per the tie-up, the company will receive from Cassiopea the exclusive right to develop and commercialise WINLEVI in Japan, Australia, Ne...
- Sun Pharma gets exclusive right to commercialise Winlevi acne cream in US, CanadaSun Pharma, North America CEO Abhay Gandhi said the expiration of the applicable waiting period under the US Hart-Scott-Rodino Antitrust Im...
- Alembic Pharma gets USFDA nod for generic acne treatment gelAlembic Pharmaceuticals on Friday said its joint venture has received nod from the US health regulator for generic Adapalene gel used for t...
- Sun Pharma surges after USFDA approves drug application for acne treatmentSun Pharma surged over 3% in trade today after the drug major received approval from the US health regulator for its new drug.
- Sun Pharma gets USFDA approval for acne drugSun Pharmaceutical Industries today said it has received approval from the US health regulator for its new drug application for acne treatm...
- Sun Pharma to buy US-based DUSA Pharmaceuticals for $230 millionUnder the terms of agreement, a 100% subsidiary of Sun Pharma will commence a tender offer for all outstanding common stock of DUSA at a pr...
- Sun Pharma to acquire US dermatology company DUSA PharmaSun Pharma is to acquire US-based DUSA Pharmaceuticals, Inc, a dermatology company focused on developing and marketing its Levulan (aminole...
Load More
